Border to Coast Pensions Partnership’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$336M Buy
2,064,415
+131,454
+7% +$21.9M 4.63% 6
2026
Q2
$361M Sell
1,932,961
-116,697
-6% -$21.9M 5.33% 3
2026
Q1
$398M Buy
+2,049,658
New +$395M 6.73% 1

Other funds holding AZN

Border to Coast Pensions Partnership's AZN Position: Q3 2026 in Review

Border to Coast Pensions Partnership increased its AstraZeneca (AZN) stake by 6.8% in Q3 2026, buying an estimated $21.9M and bringing the position to 2,064,415 shares worth $336M. The position accounts for 4.63% of the portfolio, ranked #6.

Border to Coast Pensions Partnership first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $398M in Q1 2026. 137 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Border to Coast Pensions Partnership held 2,064,415 shares of AstraZeneca worth $336M as of Q3 2026.
  • Border to Coast Pensions Partnership bought 131,454 AstraZeneca shares in Q3 2026, an estimated $21.9M.
  • AstraZeneca made up 4.63% of Border to Coast Pensions Partnership's portfolio in Q3 2026, its #6 holding.
  • Border to Coast Pensions Partnership first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • Border to Coast Pensions Partnership's AstraZeneca position peaked at $398M in Q1 2026.
  • 137 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Border to Coast Pensions Partnership's 13F filing for Q3 2026, filed 9 Oct 2026.